Early research (Phase 1)Study completedNCT03007810What this trial is testingSafety and Pharmacokinetics of Hemay005 In Healthy Male SubjectsWho this might be right forPsoriasis Tianjin Hemay Bio-Tech Co., Ltd 68
Large-scale testing (Phase 3)Study completedNCT01782924What this trial is testingClinical Study of KHK4827Who this might be right forPsoriasis Kyowa Kirin Co., Ltd. 145
Not applicableStudy completedNCT02361385What this trial is testingPBR28 PET and Inflammatory ArthritisWho this might be right forRheumatoid ArthritisPsoriatic Arthritis University of Oxford 22
Testing effectiveness (Phase 2)Ended earlyNCT03320876What this trial is testingAn Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.Who this might be right forPsoriatic Arthritis Lakefront Biotherapeutics NV 122
Not applicableStudy completedNCT00830817What this trial is testingDouble-Blind Study of Topical WBI-1001 Cream on Patients With PsoriasisWho this might be right forPsoriasis Welichem Biotech Inc. 36
Large-scale testing (Phase 3)Study completedNCT00338143What this trial is testingEvaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic TherapiesWho this might be right forPsoriasis Genentech, Inc. 1,200
Post-approval studies (Phase 4)Study completedNCT02592018What this trial is testingImmunologic Response to Secukinumab in Plaque PsoriasisWho this might be right forPsoriasis University of California, San Francisco 15
Not applicableStudy completedNCT04459780What this trial is testingCharacterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With PsoriasisWho this might be right forPsoriasis Pierre Fabre Dermo Cosmetique 40
Not applicableStudy completedNCT02028169What this trial is testingTo Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)Who this might be right forPsoriatic ArthritisWork Productivity AbbVie 120
Not applicableStudy completedNCT06050330What this trial is testingCD4+ T Cells and S100A7 Epression in Normal and Psoriatic Skin: A Histological and Histochemical StudyWho this might be right forPsoriasis Sohag University 40
Post-approval studies (Phase 4)Looking for participantsNCT07401992What this trial is testingEffects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in PsoriasisWho this might be right forPsoriasis (PsO)Obesity & OverweightDiabetes Mellitus - Type 2 Hospital Universitario Dr. Jose E. Gonzalez 62
Not applicableActive Not RecruitingNCT06247319What this trial is testingStudy to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in GreeceWho this might be right forModerate Plaque PsoriasisModerate PsoriasisPsoriasis AbbVie 250
Not applicableActive Not RecruitingNCT02775500What this trial is testingApremilast Pregnancy Exposure RegistryWho this might be right forPsoriatic ArthritisPsoriasis University of California, San Diego 233
Not applicableNot Yet RecruitingNCT07648836What this trial is testingEvaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic ArthritisWho this might be right forAnkylosing SpondylitisPsoriasis Assiut University 90
Not applicableStudy completedNCT02191007What this trial is testingEfficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to PsoriasisWho this might be right forPsoriasis Xijing Hospital 230
Testing effectiveness (Phase 2)Study completedNCT02483234What this trial is testingPsoriasis-Arthritis & Bone ProgramWho this might be right forPsoriasisPsoriatic Arthritis University of Erlangen-Nürnberg Medical School 40
Testing effectiveness (Phase 2)Study completedNCT01022502What this trial is testingComparison of Refined and Crude Indigo Naturalis Ointment in Treating PsoriasisWho this might be right forPsoriasis Vulgaris Yin-ku Lin 38
Post-approval studies (Phase 4)Study completedNCT03440736What this trial is testingComparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic SyndromeWho this might be right forPsoriasisMetabolic Syndrome Novartis Pharmaceuticals 781
Testing effectiveness (Phase 2)Study completedNCT00746772What this trial is testingEfficacy of Purslane in Treatment of Oral Lichen PlanusWho this might be right forLichen Planus, Oral Qazvin University Of Medical Sciences 37
Large-scale testing (Phase 3)Study completedNCT02065713What this trial is testingEfficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis PatientsWho this might be right forPsoriatic Arthritis Instituto de Medicina Molecular João Lobo Antunes 44